AXA IM expands healthcare team
AXA Investment Managers (AXA IM) has announced the appointment of Dani Saurymper as fund manager of the AXA Framlington Health fund and the AXA WF Framlington Health subject to regulatory approval.
Saurymper is set to join AXA IM on Monday, 27 April. Prior to that, he worked as equity research analyst European healthcare at from Barclays Capital. Before that, he spent three years at Nomura where he covered global pharmaceuticals and healthcare and nine years at Goldman Sachs as part of their European pharmaceuticals research team.
Mark Beveridge, global head of AXA Framlington comments: “We are excited to welcome Dani to AXA IM to reinforce the strength of our healthcare franchise. With 14 years’ experience, he brings an exceptional understanding of the global healthcare sector. Dani’s appointment supports our commitment to meeting clients’ needs and appetite for investing in healthcare.”